{"transactions":[{"id":312270,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T00:44:17.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":8577,"price":116.26,"value":997162.02,"ownership":{"direct":true},"balance_after":90407,"source":{"system":"sec-edgar","filing":"0001530893-26-000004","document":"form4-03042026_120314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000153089326000004/form4-03042026_120314.xml","form_type":"4"}},{"id":312716,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2026-02-26T23:11:42.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":111533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 37,177 on February 24, 2027, 37,178 on February 24, 2028, and 37,178\n on February 24, 2029."}],"balance_after":111533,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":111533},"source":{"system":"sec-edgar","filing":"0001530893-26-000002","document":"form4-02262026_110237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000153089326000002/form4-02262026_110237.xml","form_type":"4"}},{"id":312715,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-02-26T23:11:42.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":27056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":98984,"source":{"system":"sec-edgar","filing":"0001530893-26-000002","document":"form4-02262026_110237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000153089326000002/form4-02262026_110237.xml","form_type":"4"}},{"id":324411,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2025-03-07T23:55:17.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":80.98,"exercise_date":"2022-06-10","expiration_date":"2029-06-09","underlying":"Common shares","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-25-007453","document":"form4-03072025_110313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925007453/form4-03072025_110313.xml","form_type":"4"}},{"id":324410,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2025-03-07T23:55:17.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":false,"shares":91167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":200,"derivative":{"exercise_price":80.98,"exercise_date":"2022-06-10","expiration_date":"2029-06-09","underlying":"Common shares","underlying_shares":91167},"source":{"system":"sec-edgar","filing":"0001415889-25-007453","document":"form4-03072025_110313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925007453/form4-03072025_110313.xml","form_type":"4"}},{"id":324409,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-03-07T23:55:17.000Z","date":"2025-03-07","kind":"sale","planned":false,"acquired":false,"shares":200,"price":136.645,"value":27329.0,"ownership":{"direct":true},"balance_after":71928,"source":{"system":"sec-edgar","filing":"0001415889-25-007453","document":"form4-03072025_110313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925007453/form4-03072025_110313.xml","form_type":"4"}},{"id":324408,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-03-07T23:55:17.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":200,"price":80.98,"value":16196.0,"ownership":{"direct":true},"balance_after":72128,"source":{"system":"sec-edgar","filing":"0001415889-25-007453","document":"form4-03072025_110313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925007453/form4-03072025_110313.xml","form_type":"4"}},{"id":324407,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-03-07T23:55:17.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":91167,"price":133.82,"value":12199967.94,"ownership":{"direct":true},"balance_after":71928,"source":{"system":"sec-edgar","filing":"0001415889-25-007453","document":"form4-03072025_110313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925007453/form4-03072025_110313.xml","form_type":"4"}},{"id":324406,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-03-07T23:55:17.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":true,"shares":91167,"price":80.98,"value":7382703.66,"ownership":{"direct":true},"balance_after":163095,"source":{"system":"sec-edgar","filing":"0001415889-25-007453","document":"form4-03072025_110313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925007453/form4-03072025_110313.xml","form_type":"4"}},{"id":324620,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-03-05T00:27:42.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":8322,"price":135.87,"value":1130710.14,"ownership":{"direct":true},"balance_after":71928,"source":{"system":"sec-edgar","filing":"0001415889-25-006743","document":"form4-03052025_120339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925006743/form4-03052025_120339.xml","form_type":"4"}},{"id":325049,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2025-02-27T22:58:57.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":69977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 23,325 on February 25, 2026, 23,326 on February 25, 2027, and 23,326 on February 25, 2028."}],"balance_after":69977,"derivative":{"exercise_price":135.42,"exercise_date":"2026-02-25","expiration_date":"2035-02-24","underlying":"Common Shares","underlying_shares":69977},"source":{"system":"sec-edgar","filing":"0001415889-25-005886","document":"form4-02272025_100253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925005886/form4-02272025_100253.xml","form_type":"4"}},{"id":325048,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-02-27T22:58:57.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":18788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":80250,"source":{"system":"sec-edgar","filing":"0001415889-25-005886","document":"form4-02272025_100253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925005886/form4-02272025_100253.xml","form_type":"4"}},{"id":334003,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-05-08T21:00:57.000Z","date":"2024-05-07","kind":"sale","planned":false,"acquired":false,"shares":22852,"price":106.2541,"value":2428118.6932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.08 to $106.39, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":61462,"source":{"system":"sec-edgar","filing":"0001415889-24-012624","document":"form4-05082024_090550.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924012624/form4-05082024_090550.xml","form_type":"4"}},{"id":338509,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-03-04T23:50:12.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":694,"price":118.5,"value":82239.0,"ownership":{"direct":true},"balance_after":84314,"source":{"system":"sec-edgar","filing":"0001415889-24-006405","document":"form4-03042024_110302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924006405/form4-03042024_110302.xml","form_type":"4"}},{"id":338508,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-03-04T23:50:12.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":7669,"price":120.05,"value":920663.45,"ownership":{"direct":true},"balance_after":85008,"source":{"system":"sec-edgar","filing":"0001415889-24-006405","document":"form4-03042024_110302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924006405/form4-03042024_110302.xml","form_type":"4"}},{"id":339296,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2024-02-23T22:33:25.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":64787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 21,595 on February 21, 2025, 21,596 on February 21, 2026, and 21,596 on February 21, 2027."}],"balance_after":64787,"derivative":{"exercise_price":116.98,"exercise_date":"2025-02-21","expiration_date":"2034-02-20","underlying":"Common Shares","underlying_shares":64787},"source":{"system":"sec-edgar","filing":"0001415889-24-005098","document":"form4-02232024_100219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924005098/form4-02232024_100219.xml","form_type":"4"}},{"id":339295,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2024-02-23T22:33:25.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":17240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":92677,"source":{"system":"sec-edgar","filing":"0001415889-24-005098","document":"form4-02232024_100219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924005098/form4-02232024_100219.xml","form_type":"4"}},{"id":352016,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:27:37.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":943,"price":100.7,"value":94960.1,"ownership":{"direct":true},"balance_after":75437,"source":{"system":"sec-edgar","filing":"0001415889-23-003901","document":"form4-03032023_120327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003901/form4-03032023_120327.xml","form_type":"4"}},{"id":352015,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:27:37.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":7631,"price":99.77,"value":761344.87,"ownership":{"direct":true},"balance_after":76380,"source":{"system":"sec-edgar","filing":"0001415889-23-003901","document":"form4-03032023_120327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003901/form4-03032023_120327.xml","form_type":"4"}},{"id":352760,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2023-02-22T23:48:07.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":62527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,842 on February 17, 2024, 20,842 on February 17, 2025, and 20,843 on February 17, 2026."}],"balance_after":62527,"derivative":{"exercise_price":106.24,"exercise_date":"2024-02-17","expiration_date":"2033-02-16","underlying":"Common Shares","underlying_shares":62527},"source":{"system":"sec-edgar","filing":"0001415889-23-003050","document":"form4-02222023_110253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003050/form4-02222023_110253.xml","form_type":"4"}},{"id":352759,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-02-22T23:48:07.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":15855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":84011,"source":{"system":"sec-edgar","filing":"0001415889-23-003050","document":"form4-02222023_110253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003050/form4-02222023_110253.xml","form_type":"4"}},{"id":360353,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-06-14T21:18:07.000Z","date":"2022-06-10","kind":"tax_withholding","acquired":false,"shares":19592,"price":112.71,"value":2208214.32,"ownership":{"direct":true},"balance_after":68156,"source":{"system":"sec-edgar","filing":"0001415889-22-006538","document":"form4-06142022_020653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922006538/form4-06142022_020653.xml","form_type":"4"}},{"id":360352,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-06-14T21:18:07.000Z","date":"2022-06-10","kind":"tax_withholding","acquired":false,"shares":2882,"price":112.71,"value":324830.22,"ownership":{"direct":true},"balance_after":87748,"source":{"system":"sec-edgar","filing":"0001415889-22-006538","document":"form4-06142022_020653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922006538/form4-06142022_020653.xml","form_type":"4"}},{"id":364708,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:38:43.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":943,"price":118.1503,"value":111415.7329,"ownership":{"direct":true},"balance_after":90630,"source":{"system":"sec-edgar","filing":"0001415889-22-002190","document":"form4-03022022_040309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002190/form4-03022022_040309.xml","form_type":"4"}},{"id":364707,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:38:43.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":5168,"price":122.41,"value":632614.88,"ownership":{"direct":true},"balance_after":91573,"source":{"system":"sec-edgar","filing":"0001415889-22-002190","document":"form4-03022022_040309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002190/form4-03022022_040309.xml","form_type":"4"}},{"id":365291,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2022-02-24T01:07:22.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":80380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 26,793 on February 18, 2023, 26,793 on February 18, 2024, and 26,794 on February 18, 2025."}],"balance_after":80380,"derivative":{"exercise_price":117.58,"exercise_date":"2023-02-18","expiration_date":"2032-02-17","underlying":"Common Shares","underlying_shares":80380},"source":{"system":"sec-edgar","filing":"0001415889-22-001734","document":"form4-02232022_050212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001734/form4-02232022_050212.xml","form_type":"4"}},{"id":365290,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:07:22.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":17247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":96741,"source":{"system":"sec-edgar","filing":"0001415889-22-001734","document":"form4-02232022_050212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001734/form4-02232022_050212.xml","form_type":"4"}},{"id":374425,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-06-11T21:09:51.000Z","date":"2021-06-10","kind":"tax_withholding","acquired":false,"shares":2881,"price":109.05,"value":314173.05,"ownership":{"direct":true},"balance_after":79494,"source":{"system":"sec-edgar","filing":"0001415889-21-002958","document":"form4-06112021_020627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921002958/form4-06112021_020627.xml","form_type":"4"}},{"id":379024,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:16:24.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":943,"price":120.61,"value":113735.23,"ownership":{"direct":true},"balance_after":82375,"source":{"system":"sec-edgar","filing":"0001415889-21-001201","document":"form4-03022021_040300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001201/form4-03022021_040300.xml","form_type":"4"}},{"id":379023,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:16:24.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":2621,"price":121.58,"value":318661.18,"ownership":{"direct":true},"balance_after":83318,"source":{"system":"sec-edgar","filing":"0001415889-21-001201","document":"form4-03022021_040300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001201/form4-03022021_040300.xml","form_type":"4"}},{"id":379669,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-02-23T23:45:02.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":71070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 23,690 on February 19, 2022, 23,690 on February 19, 2023, and 23,690 on February 19, 2024."}],"balance_after":71070,"derivative":{"exercise_price":124.04,"exercise_date":"2022-02-19","expiration_date":"2031-02-18","underlying":"Common Shares","underlying_shares":71070},"source":{"system":"sec-edgar","filing":"0001415889-21-000890","document":"form4-02232021_030231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000890/form4-02232021_030231.xml","form_type":"4"}},{"id":379668,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-23T23:45:02.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":13865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":85939,"source":{"system":"sec-edgar","filing":"0001415889-21-000890","document":"form4-02232021_030231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000890/form4-02232021_030231.xml","form_type":"4"}},{"id":389294,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-06-12T21:07:15.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":872,"price":90.844,"value":79215.968,"ownership":{"direct":true},"balance_after":72074,"source":{"system":"sec-edgar","filing":"0001179110-20-007293","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020007293/edgar.xml","form_type":"4"}},{"id":389293,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-06-12T21:07:15.000Z","date":"2020-06-10","kind":"tax_withholding","acquired":false,"shares":2855,"price":90.27,"value":257720.85,"ownership":{"direct":true},"balance_after":72946,"source":{"system":"sec-edgar","filing":"0001179110-20-007293","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020007293/edgar.xml","form_type":"4"}},{"id":394471,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2020-02-25T22:36:23.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":114940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,313 on February 21, 2021, 38,313 on February 21, 2022, and 38,314 on February 21, 2023."}],"balance_after":114940,"derivative":{"exercise_price":87.72,"exercise_date":"2021-02-21","expiration_date":"2030-02-20","underlying":"Common shares","underlying_shares":114940},"source":{"system":"sec-edgar","filing":"0001179110-20-002291","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002291/edgar.xml","form_type":"4"}},{"id":394470,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-25T22:36:23.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":18855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":75801,"source":{"system":"sec-edgar","filing":"0001179110-20-002291","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002291/edgar.xml","form_type":"4"}},{"id":3455172,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":48333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 23, 2013, 1/48th of the shares subject to the option vested on December 30, 2013 and 1/48th of the shares subject to\nthe option vested monthly thereafter over 47 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 23, 2013, 1/48th of the shares subject to the option vested on December 30, 2013 and 1/48th of the shares subject to\nthe option vested monthly thereafter over 47 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 23, 2013, 1/48th of the shares subject to the option vested on December 30, 2013 and 1/48th of the shares subject to\nthe option vested monthly thereafter over 47 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."}],"balance_after":48333,"derivative":{"exercise_price":1.2,"expiration_date":"2019-12-06","underlying":"Common Stock","underlying_shares":48333},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455171,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"disposition_to_issuer","acquired":false,"shares":48333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 23, 2013, 1/48th of the shares subject to the option vested on December 30, 2013 and 1/48th of the shares subject to\nthe option vested monthly thereafter over 47 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 23, 2013, 1/48th of the shares subject to the option vested on December 30, 2013 and 1/48th of the shares subject to\nthe option vested monthly thereafter over 47 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on April 23, 2013, 1/48th of the shares subject to the option vested on December 30, 2013 and 1/48th of the shares subject to\nthe option vested monthly thereafter over 47 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."}],"balance_after":0,"derivative":{"exercise_price":1.2,"expiration_date":"2019-10-22","underlying":"Common Stock","underlying_shares":48333},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455170,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":45500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 18, 2017 and 1/8th of the shares subject to the option vested on July 1, 2017 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 18, 2017 and 1/8th of the shares subject to the option vested on July 1, 2017 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 18, 2017 and 1/8th of the shares subject to the option vested on July 1, 2017 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."}],"balance_after":45500,"derivative":{"exercise_price":13.05,"expiration_date":"2019-12-06","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455169,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"disposition_to_issuer","acquired":false,"shares":45500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 18, 2017 and 1/8th of the shares subject to the option vested on July 1, 2017 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 18, 2017 and 1/8th of the shares subject to the option vested on July 1, 2017 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 18, 2017 and 1/8th of the shares subject to the option vested on July 1, 2017 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."}],"balance_after":0,"derivative":{"exercise_price":13.05,"expiration_date":"2019-10-22","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455168,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":196875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 15, 2016 and vest in equal monthly installments over four years. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 15, 2016 and vest in equal monthly installments over four years. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 15, 2016 and vest in equal monthly installments over four years. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."}],"balance_after":196875,"derivative":{"exercise_price":18.9,"expiration_date":"2019-12-06","underlying":"Common Stock","underlying_shares":196875},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455167,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"disposition_to_issuer","acquired":false,"shares":196875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 15, 2016 and vest in equal monthly installments over four years. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 15, 2016 and vest in equal monthly installments over four years. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 15, 2016 and vest in equal monthly installments over four years. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."}],"balance_after":0,"derivative":{"exercise_price":18.9,"expiration_date":"2019-10-22","underlying":"Common Stock","underlying_shares":196875},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455166,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 21, 2015 and 1/8th of the shares subject to the option vested on July 1, 2015 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 21, 2015 and 1/8th of the shares subject to the option vested on July 1, 2015 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 21, 2015 and 1/8th of the shares subject to the option vested on July 1, 2015 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."}],"balance_after":150000,"derivative":{"exercise_price":21.06,"expiration_date":"2019-12-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455165,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"disposition_to_issuer","acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 21, 2015 and 1/8th of the shares subject to the option vested on July 1, 2015 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 21, 2015 and 1/8th of the shares subject to the option vested on July 1, 2015 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 21, 2015 and 1/8th of the shares subject to the option vested on July 1, 2015 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019."}],"balance_after":0,"derivative":{"exercise_price":21.06,"expiration_date":"2019-10-22","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455164,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":19688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 16, 2019 and 1/8th of the shares subject to the option vested on July 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 16, 2019 and 1/8th of the shares subject to the option vested on July 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 16, 2019 and 1/8th of the shares subject to the option vested on July 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."}],"balance_after":19688,"derivative":{"exercise_price":28.58,"expiration_date":"2019-12-06","underlying":"Common Stock","underlying_shares":19688},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455163,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"disposition_to_issuer","acquired":false,"shares":19688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 16, 2019 and 1/8th of the shares subject to the option vested on July 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 16, 2019 and 1/8th of the shares subject to the option vested on July 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 16, 2019 and 1/8th of the shares subject to the option vested on July 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."}],"balance_after":0,"derivative":{"exercise_price":28.58,"expiration_date":"2019-10-22","underlying":"Common Stock","underlying_shares":19688},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455162,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":44625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 17, 2018 and 1/8th of the shares subject to the option vested on July 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 17, 2018 and 1/8th of the shares subject to the option vested on July 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 17, 2018 and 1/8th of the shares subject to the option vested on July 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."}],"balance_after":44625,"derivative":{"exercise_price":33.95,"expiration_date":"2019-12-06","underlying":"Common Stock","underlying_shares":44625},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":3455161,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-07-26T16:55:52.000Z","date":"2019-07-24","kind":"disposition_to_issuer","acquired":false,"shares":44625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 17, 2018 and 1/8th of the shares subject to the option vested on July 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 17, 2018 and 1/8th of the shares subject to the option vested on July 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option extending the post-termination exercise period from 90 days to 135 days, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on January 17, 2018 and 1/8th of the shares subject to the option vested on July 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter over 42 months. The number of shares reflected herein represent the number of outstanding shares that have vested as of July 24, 2019.  All other shares subject to the 'old' option have been cancelled."}],"balance_after":0,"derivative":{"exercise_price":33.95,"expiration_date":"2019-10-22","underlying":"Common Stock","underlying_shares":44625},"source":{"system":"sec-edgar","filing":"0001562180-19-004078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019004078/primarydocument.xml","form_type":"4"}},{"id":402252,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2019-06-12T21:08:49.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":91367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,455 on June 10, 2020, 30,456 on June 10, 2021, and 30,456 on June 10, 2022."}],"balance_after":91367,"derivative":{"exercise_price":80.98,"exercise_date":"2020-06-10","expiration_date":"2029-06-09","underlying":"Common shares","underlying_shares":91367},"source":{"system":"sec-edgar","filing":"0001179110-19-007549","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019007549/edgar.xml","form_type":"4"}},{"id":402251,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-06-12T21:08:49.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":39515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program.  The award has a 3-year term, with the award vesting on June 10, 2022. The award includes the right to have shares withheld for tax purposes."}],"balance_after":56946,"source":{"system":"sec-edgar","filing":"0001179110-19-007549","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019007549/edgar.xml","form_type":"4"}},{"id":402250,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-06-12T21:08:49.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":17431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":17431,"source":{"system":"sec-edgar","filing":"0001179110-19-007549","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019007549/edgar.xml","form_type":"4"}},{"id":3520457,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-17T16:06:17.000Z","date":"2019-05-15","kind":"exercise","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting commencement date of the option was January 1st, 2017. 1/8th of the shares subject to the option vested on July 1st, 2017 and 1/48th of the shares subject to the option vests monthly thereafter over 42 months."}],"balance_after":140000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001562180-19-002944","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019002944/primarydocument.xml","form_type":"4"}},{"id":3520456,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-17T16:06:17.000Z","date":"2019-05-15","kind":"sale","acquired":false,"shares":9500,"price":25.5897,"value":243102.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $25.31 to $25.92, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 68,800 Restricted Stock Units."}],"balance_after":421983,"source":{"system":"sec-edgar","filing":"0001562180-19-002944","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019002944/primarydocument.xml","form_type":"4"}},{"id":3520455,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-17T16:06:17.000Z","date":"2019-05-15","kind":"exercise","acquired":true,"shares":9500,"price":13.05,"value":123975.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 68,800 Restricted Stock Units."}],"balance_after":431483,"source":{"system":"sec-edgar","filing":"0001562180-19-002944","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019002944/primarydocument.xml","form_type":"4"}},{"id":3553495,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-17T15:48:09.000Z","date":"2019-04-15","kind":"exercise","acquired":false,"shares":6016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting commencement date of the option is November 30, 2013. 1/48th of the shares subject to the option shall vest on December 30, 2013 and 1/48th of the shares subject to the option shall vest monthly thereafter over 47 months."}],"balance_after":48333,"derivative":{"exercise_price":1.2,"expiration_date":"2023-04-22","underlying":"Common Stock","underlying_shares":6016},"source":{"system":"sec-edgar","filing":"0001562180-19-002289","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019002289/primarydocument.xml","form_type":"4"}},{"id":3553494,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-17T15:48:09.000Z","date":"2019-04-15","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":149500,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001562180-19-002289","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019002289/primarydocument.xml","form_type":"4"}},{"id":3553493,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-04-17T15:48:09.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":29588,"price":28.4319,"value":841243.0572,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $28.05 to $29.055, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 68,800 Restricted Stock Units."}],"balance_after":421983,"source":{"system":"sec-edgar","filing":"0001562180-19-002289","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019002289/primarydocument.xml","form_type":"4"}},{"id":3553492,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-04-17T15:48:09.000Z","date":"2019-04-15","kind":"exercise","acquired":true,"shares":6016,"price":1.2,"value":7219.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 68,800 Restricted Stock Units."}],"balance_after":451571,"source":{"system":"sec-edgar","filing":"0001562180-19-002289","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019002289/primarydocument.xml","form_type":"4"}},{"id":3553491,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-04-17T15:48:09.000Z","date":"2019-04-15","kind":"exercise","acquired":true,"shares":7500,"price":13.05,"value":97875.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 68,800 Restricted Stock Units."}],"balance_after":445555,"source":{"system":"sec-edgar","filing":"0001562180-19-002289","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019002289/primarydocument.xml","form_type":"4"}},{"id":3691696,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-18T17:38:54.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting commencement date of the option is January 1, 2019.  1/8th of the shares subject to the option shall vest on July 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":157500,"derivative":{"exercise_price":28.58,"expiration_date":"2029-01-15","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001562180-19-000374","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019000374/primarydocument.xml","form_type":"4"}},{"id":3691695,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-18T17:38:54.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":33800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan.  Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting.  The restricted stock units vest in three equal annual installments commencing on January 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 68,800 Restricted Stock Units."}],"balance_after":438055,"source":{"system":"sec-edgar","filing":"0001562180-19-000374","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019000374/primarydocument.xml","form_type":"4"}},{"id":3708158,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-03T20:11:12.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":10428,"price":26.5675,"value":277045.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares tendered in payment of the tax withholding obligation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $26.43 to $26.86, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 35,000 Restricted Stock Units."}],"balance_after":404255,"source":{"system":"sec-edgar","filing":"0001562180-19-000165","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019000165/primarydocument.xml","form_type":"4"}},{"id":3718857,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-26T12:43:55.000Z","date":"2018-12-20","kind":"exercise","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting commencement date of the option is November 30, 2013.  1/48th of the shares subject to the option shall vest monthly thereafter over 48 months."}],"balance_after":54349,"derivative":{"exercise_price":1.2,"expiration_date":"2023-04-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001562180-18-005094","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018005094/primarydocument.xml","form_type":"4"}},{"id":3718856,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-26T12:43:55.000Z","date":"2018-12-20","kind":"exercise","acquired":true,"shares":35000,"price":1.2,"value":42000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":414683,"source":{"system":"sec-edgar","filing":"0001562180-18-005094","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018005094/primarydocument.xml","form_type":"4"}},{"id":3724510,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-19T17:16:45.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":157000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-18-005054","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018005054/primarydocument.xml","form_type":"4"}},{"id":3724509,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-19T17:16:45.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":20000,"price":29.7252,"value":594504.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $29.31 to $30.53, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":379683,"source":{"system":"sec-edgar","filing":"0001562180-18-005054","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018005054/primarydocument.xml","form_type":"4"}},{"id":3724508,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-19T17:16:45.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":5000,"price":13.05,"value":65250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":399683,"source":{"system":"sec-edgar","filing":"0001562180-18-005054","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018005054/primarydocument.xml","form_type":"4"}},{"id":3758661,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-19T16:43:48.000Z","date":"2018-11-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":162000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-18-004613","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018004613/primarydocument.xml","form_type":"4"}},{"id":3758660,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-19T16:43:48.000Z","date":"2018-11-15","kind":"sale","acquired":false,"shares":20000,"price":30.0148,"value":600296.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $29.15 to $30.955, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":394683,"source":{"system":"sec-edgar","filing":"0001562180-18-004613","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018004613/primarydocument.xml","form_type":"4"}},{"id":3758659,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-19T16:43:48.000Z","date":"2018-11-15","kind":"exercise","acquired":true,"shares":5000,"price":13.05,"value":65250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":414683,"source":{"system":"sec-edgar","filing":"0001562180-18-004613","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018004613/primarydocument.xml","form_type":"4"}},{"id":3788064,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-17T18:54:56.000Z","date":"2018-10-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":167000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-18-004243","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018004243/primarydocument.xml","form_type":"4"}},{"id":3788063,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-10-17T18:54:56.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":20000,"price":29.6307,"value":592614.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $29.37 to $30.34, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":409683,"source":{"system":"sec-edgar","filing":"0001562180-18-004243","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018004243/primarydocument.xml","form_type":"4"}},{"id":3788062,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-10-17T18:54:56.000Z","date":"2018-10-15","kind":"exercise","acquired":true,"shares":5000,"price":13.05,"value":65250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":429683,"source":{"system":"sec-edgar","filing":"0001562180-18-004243","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018004243/primarydocument.xml","form_type":"4"}},{"id":3811484,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-19T17:27:29.000Z","date":"2018-09-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":172000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-18-003986","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003986/primarydocument.xml","form_type":"4"}},{"id":3811483,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-09-19T17:27:29.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":20000,"price":29.1431,"value":582862.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $28.85 to $30.00, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":424683,"source":{"system":"sec-edgar","filing":"0001562180-18-003986","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003986/primarydocument.xml","form_type":"4"}},{"id":3811482,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-09-19T17:27:29.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":5000,"price":13.05,"value":65250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":444683,"source":{"system":"sec-edgar","filing":"0001562180-18-003986","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003986/primarydocument.xml","form_type":"4"}},{"id":3839782,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-17T19:05:55.000Z","date":"2018-08-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":177000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-18-003704","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003704/primarydocument.xml","form_type":"4"}},{"id":3839781,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-17T19:05:55.000Z","date":"2018-08-15","kind":"sale","acquired":false,"shares":20000,"price":26.5097,"value":530194.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $26.15 to $27.05, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":439683,"source":{"system":"sec-edgar","filing":"0001562180-18-003704","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003704/primarydocument.xml","form_type":"4"}},{"id":3839780,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-17T19:05:55.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":5000,"price":13.05,"value":65250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,500 Restricted Stock Units."}],"balance_after":459683,"source":{"system":"sec-edgar","filing":"0001562180-18-003704","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003704/primarydocument.xml","form_type":"4"}},{"id":3865136,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-18T18:09:12.000Z","date":"2018-07-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":182000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-18-003331","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003331/primarydocument.xml","form_type":"4"}},{"id":3865135,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-18T18:09:12.000Z","date":"2018-07-16","kind":"sale","acquired":false,"shares":20000,"price":33.0843,"value":661686.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $32.90 to $33.55, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":454683,"source":{"system":"sec-edgar","filing":"0001562180-18-003331","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003331/primarydocument.xml","form_type":"4"}},{"id":3865134,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-18T18:09:12.000Z","date":"2018-07-16","kind":"exercise","acquired":true,"shares":5000,"price":13.05,"value":65250.0,"ownership":{"direct":true},"balance_after":474683,"source":{"system":"sec-edgar","filing":"0001562180-18-003331","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003331/primarydocument.xml","form_type":"4"}},{"id":3888366,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-19T17:22:47.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":187000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-18-003060","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003060/primarydocument.xml","form_type":"4"}},{"id":3888365,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-06-19T17:22:47.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":20000,"price":36.7855,"value":735710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $36.55 to $37.05, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":469683,"source":{"system":"sec-edgar","filing":"0001562180-18-003060","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003060/primarydocument.xml","form_type":"4"}},{"id":3888364,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-06-19T17:22:47.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":5000,"price":13.05,"value":65250.0,"ownership":{"direct":true},"balance_after":489683,"source":{"system":"sec-edgar","filing":"0001562180-18-003060","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003060/primarydocument.xml","form_type":"4"}},{"id":3920425,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-23T19:16:23.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":3785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 21, 2018 or (ii) the next Annual Meeting following May 21, 2018, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,785 RSUs."}],"balance_after":5303,"source":{"system":"sec-edgar","filing":"0001140361-18-025420","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000114036118025420/doc1.xml","form_type":"4"}},{"id":3927730,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-17T16:39:44.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":192000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-18-002535","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018002535/primarydocument.xml","form_type":"4"}},{"id":3927729,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-17T16:39:44.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":15000,"price":39.2163,"value":588244.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $39.00 to $39.35, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":484683,"source":{"system":"sec-edgar","filing":"0001562180-18-002535","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018002535/primarydocument.xml","form_type":"4"}},{"id":3927728,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-17T16:39:44.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":15000,"price":13.05,"value":195750.0,"ownership":{"direct":true},"balance_after":499683,"source":{"system":"sec-edgar","filing":"0001562180-18-002535","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018002535/primarydocument.xml","form_type":"4"}},{"id":3961978,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-04-17T17:31:00.000Z","date":"2018-04-16","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option vested on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":207000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-18-001903","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018001903/primarydocument.xml","form_type":"4"}},{"id":3961977,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-04-17T17:31:00.000Z","date":"2018-04-16","kind":"sale","acquired":false,"shares":15000,"price":39.5945,"value":593917.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $39.35 to $39.80, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4."}],"balance_after":484683,"source":{"system":"sec-edgar","filing":"0001562180-18-001903","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018001903/primarydocument.xml","form_type":"4"}},{"id":3961976,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-04-17T17:31:00.000Z","date":"2018-04-16","kind":"exercise","acquired":true,"shares":15000,"price":13.05,"value":195750.0,"ownership":{"direct":true},"balance_after":499683,"source":{"system":"sec-edgar","filing":"0001562180-18-001903","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018001903/primarydocument.xml","form_type":"4"}},{"id":3992123,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-16T18:42:40.000Z","date":"2018-03-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting commencement date of the option is January 1, 2017. 1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":222000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-18-001657","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018001657/primarydocument.xml","form_type":"4"}},{"id":3992122,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-16T18:42:40.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":15000,"price":38.3194,"value":574791.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $38.15 to $38.55, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4."}],"balance_after":484683,"source":{"system":"sec-edgar","filing":"0001562180-18-001657","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018001657/primarydocument.xml","form_type":"4"}},{"id":3992121,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-16T18:42:40.000Z","date":"2018-03-15","kind":"exercise","acquired":true,"shares":15000,"price":13.05,"value":195750.0,"ownership":{"direct":true},"balance_after":499683,"source":{"system":"sec-edgar","filing":"0001562180-18-001657","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018001657/primarydocument.xml","form_type":"4"}},{"id":4051600,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T17:44:52.000Z","date":"2018-02-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting commencement date of the option is January 1, 2017.  1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months."}],"balance_after":237000,"derivative":{"exercise_price":13.05,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-18-001054","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018001054/primarydocument.xml","form_type":"4"}},{"id":4051599,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-16T17:44:52.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":15000,"price":36.3959,"value":545938.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $36.25 to $36.95, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4."}],"balance_after":484683,"source":{"system":"sec-edgar","filing":"0001562180-18-001054","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018001054/primarydocument.xml","form_type":"4"}},{"id":4051598,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-16T17:44:52.000Z","date":"2018-02-15","kind":"exercise","acquired":true,"shares":15000,"price":13.05,"value":195750.0,"ownership":{"direct":true},"balance_after":499683,"source":{"system":"sec-edgar","filing":"0001562180-18-001054","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018001054/primarydocument.xml","form_type":"4"}},{"id":4094447,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options (Right to buy)","published_at":"2018-01-19T17:17:21.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":119000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/8th of the shares subject to the option vest on July 1, 2018 and 1/48th of the total shares subject to the option vest monthly thereafter over 42 months."}],"balance_after":119000,"derivative":{"exercise_price":33.95,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":119000},"source":{"system":"sec-edgar","filing":"0001562180-18-000368","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018000368/primarydocument.xml","form_type":"4"}},{"id":4094446,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-19T17:17:21.000Z","date":"2018-01-18","kind":"sale","acquired":false,"shares":11166,"price":33.4672,"value":373694.7552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $33.20 to $33.80, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4."}],"balance_after":484683,"source":{"system":"sec-edgar","filing":"0001562180-18-000368","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018000368/primarydocument.xml","form_type":"4"}}],"next_cursor":"2018-01-19T17:17:21.000000Z,4094446"}